EBITDA for the quarter rose by 19.8 per cent yoy to Rs. 21.2 crore with a corresponding margin contraction of 795 bps. EBITDA margin for the quarter stood at 15 per cent. The PAT for the quarter came in at Rs. 10.22 crore, yoy increase of 77.4 per cent.

In the last few months, mutual fund investors have been witnessing the consistency in the losses from their mutual fund investment. You must have heard many times, of late, that the Indian markets are falling due to weak global cues or due to macroeconomic aspects. 

The exchanges had asked the two companies to clarify if any stake deal is been contemplated between the companies as published in a leading newspaper which spoke of Allcargo Logistics negotiating a deal to buy a controlling stake in Gati.

On the last trading session of the week, we may see the market opening on a flat note and there is likelihood that it may continue to trade in a range before the index kicks off the next leg of the rally. Stocks in news: Maruti Suzuki India, BEML, Gati, TCS, Persistent Systems, Tree House Education and Accessories, NBCC, Astrazeneca Pharma, Lemon Tree Hotels, MCX, ION Exchange and Cosmo Films.

A quiet opening is expected for the Indian markets and we may see the markets trading in a range with stock-specific movement. The muted trend in the SGX Nifty suggests that Nifty could open unchanged at 11,421.  

The stocks that are likely to witness significant movement on the bourses on August 17 are Cosmo Films, V-Mart, Tata Consultancy Services, Niraj Ispat Ind. and Infibeam.

On August 14, 2018, Andhra Pradesh Capital Region Development Authority (“APCRDA”) successfully raised Rs. 2000 crores by issuing bonds on private placement basis using BSE BOND platform.

The share price of Patel Engineering Company jumped about 12 per cent on Thursday after the company reported profit of Rs. 36.2 crore for the quarter ended June 2018.

This film has been specially designed to offer superior inter-layer bond strength for making multi-layer laminate structures, which in turn enhances barrier properties, said the company in a filing to the bourses.

Suven Life Sciences reported its results for the quarter ended June 30, 2018. The company’s standalone revenue for the quarter came in at Rs. 191.66 crore, registering 35.9 per cent yoy increase. This was mainly driven by a jump in revenue from the manufacturing segment by 35.2 per cent yoy.